Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients

Head and Neck

Volumn 22, Issue 7, 2000, Pages 687-693

  Robbins, K Thomas ^a   Kumar, Parvesh ^a   Wong, Frank S H ^a   Hartsell, William F ^a   Flick, Pamela ^a   Palmer, Robert ^a   Weir III, Alva B ^a   Neill, H Barry ^a   Murry, Thomas ^a   Ferguson, Robert ^a   Hanchett, Catherine ^a   Vieira, Francisco ^a   Bush, Andrew ^a   Howell, Stephen B ^b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Chemoradiation; Head and neck cancer; Intra arterial

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; RADIOSENSITIZING AGENT; THIOSULFATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HEAD AND NECK TUMOR; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIATION-SENSITIZING AGENTS; SURVIVAL RATE; THIOSULFATES;

EID: 0034294670     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0347(200010)22:7<687::AID-HED8>3.0.CO;2-W     Document Type: Article

References (22)

1. Merlano M, Benasso M, Corvo R, et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996;88(9):583-589.
2. Marcial VA, Pajak T, Mohiuddin M, et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 1990;66:1861-1868.
3. Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990;8(5):911-934.
4. Wolf GT, Hong WK, Fisher SG, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Study Group. N Engl J Med 1991;324:1685-1690.
5. Pfister DG, Harrison LB, Strong EW, Bosl GJ. Current status of larynx preservation with multimodality therapy. Oncology 1992;6(3):33-38.
6. Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB. Rapid superselective high dose cisplatin infusion for advanced head and neck malignancies. Head and Neck 1992;14:364-371.
7. Robbins KT, Storniolo AM, Kerber CK, et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 1994;12: 2113-2120.
8. Robbins KT, Hoffman R. Decadose effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract: Part I, histoculture experiments. Laryngoscope 1996; 106(1):32-36.
9. Robbins KT, Storniolo AMS, Hryniuk WH, Howell SB. Decadose effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract: Part II, clinical studies. Laryngoscope 1996;106(1):37-42.
10. Los G, Barton R, Heath DD, et al. Selective intra-arterial infusion of high dose cisplatin in advanced head and neck cancer patients resulting in high tumor platinum concentrations and cisplatin-DNA adduct formation. Ca Chemo Pharm 1995;37:150-154.
11. Robbins KT, Vicario D, Seagren S, et al. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 1994;168:419-421.
12. Robbins KT, Kumar P, Regine WF, et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 1997;38(2): 263-271.
13. Robbins KT, Fontanesi J, Wong FSH, et al. A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otol 1996;122:858-864.
14. Howell SB. Pharmacokinetic principles of regional chemotherapy. Contr Oncol 1988;29:1-8.
15. Eckman WW, Patlak CS, Fenstermacher JD. A critical evaluation of the principles governing the advantages of intra-arterial infusions. J Pharmacokinet Biopharm 1974; 2:257-285.
16. Wheeler RH, Ziessman HA, Medvec BR, et al: Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer. Cancer Res 1986;46:4200-4204.
17. Howell SB, Pfeifle CE, Wung WE, et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 1982;97:845-851.
18. Garden AS, Glisson BS, Ang KK, et al. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J Clin Oncol 1999;17(8):2390-2395.
19. Kies MS, Haraf DJ, Athanasiadis I, et al. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. J Clin Oncol 1998;16(8):2715-2721.
20. Vokes EE, Kies M, Haraf DJ, et al. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol 1995;13(4):876-883.
21. Rosen F, Vokes EE, Lad T, et al. Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study. Invest New Drugs 1995; 13(3):249-252.
22. Woodson GE, Rosen C, Murry T, Robbins KT. Assessment of vocal function in patients undergoing chemoradiation for head and neck cancer. Arch Otol 1996;122:858-864.